Domperidone‐induced pityriasis rosea‐like drug eruption

Pityriasis rosea is a common, acute, self limiting inflammatory skin disease. Pityriasis rosea‐like eruptions (PR‐LE) have been reported after drugs. The clinical presentation of PR‐LE can be distinguished from pityriasis rosea. We reporte a 41‐year‐old woman who developed PR‐LE 5 days after adminis...

Descripción completa

Detalles Bibliográficos
Autores principales: Saad, Sarra, Gammoudi, Rima, Abdessayed, Nihed, Denguezli, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981874/
https://www.ncbi.nlm.nih.gov/pubmed/35414911
http://dx.doi.org/10.1002/ccr3.5674
_version_ 1784681691622670336
author Saad, Sarra
Gammoudi, Rima
Abdessayed, Nihed
Denguezli, Mohamed
author_facet Saad, Sarra
Gammoudi, Rima
Abdessayed, Nihed
Denguezli, Mohamed
author_sort Saad, Sarra
collection PubMed
description Pityriasis rosea is a common, acute, self limiting inflammatory skin disease. Pityriasis rosea‐like eruptions (PR‐LE) have been reported after drugs. The clinical presentation of PR‐LE can be distinguished from pityriasis rosea. We reporte a 41‐year‐old woman who developed PR‐LE 5 days after administration domperidone.
format Online
Article
Text
id pubmed-8981874
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-89818742022-04-11 Domperidone‐induced pityriasis rosea‐like drug eruption Saad, Sarra Gammoudi, Rima Abdessayed, Nihed Denguezli, Mohamed Clin Case Rep Clinical Images Pityriasis rosea is a common, acute, self limiting inflammatory skin disease. Pityriasis rosea‐like eruptions (PR‐LE) have been reported after drugs. The clinical presentation of PR‐LE can be distinguished from pityriasis rosea. We reporte a 41‐year‐old woman who developed PR‐LE 5 days after administration domperidone. John Wiley and Sons Inc. 2022-04-05 /pmc/articles/PMC8981874/ /pubmed/35414911 http://dx.doi.org/10.1002/ccr3.5674 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Images
Saad, Sarra
Gammoudi, Rima
Abdessayed, Nihed
Denguezli, Mohamed
Domperidone‐induced pityriasis rosea‐like drug eruption
title Domperidone‐induced pityriasis rosea‐like drug eruption
title_full Domperidone‐induced pityriasis rosea‐like drug eruption
title_fullStr Domperidone‐induced pityriasis rosea‐like drug eruption
title_full_unstemmed Domperidone‐induced pityriasis rosea‐like drug eruption
title_short Domperidone‐induced pityriasis rosea‐like drug eruption
title_sort domperidone‐induced pityriasis rosea‐like drug eruption
topic Clinical Images
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981874/
https://www.ncbi.nlm.nih.gov/pubmed/35414911
http://dx.doi.org/10.1002/ccr3.5674
work_keys_str_mv AT saadsarra domperidoneinducedpityriasisrosealikedrugeruption
AT gammoudirima domperidoneinducedpityriasisrosealikedrugeruption
AT abdessayednihed domperidoneinducedpityriasisrosealikedrugeruption
AT denguezlimohamed domperidoneinducedpityriasisrosealikedrugeruption

Ejemplares similares